Trump Signs Executive Order Doubling AI Funding for Pediatric Cancer Research

President Trump and Pediatric Cancer

Formal Complaint about the 2025 EU4Health Operating Grant Procedure to the European Ombudswoman - AECL

Formal Complaint about the 2025 EU4Health Operating Grant Procedure to the European Ombudswoman - AECL

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

New Paper Alert: Managing Key Adverse Events of Sacituzumab Govitecan in Breast Cancer

Sacituzumab Govitecan

Julio Aguirre-Ghiso: Metastasis and the Real Causes of Cancer Mortality

Julio Aguirre-Ghiso: Metastasis and the Real Causes of Cancer Mortality

Aleix Prat: DNADX ctDNA Testing in Patients Treated with Sacituzumab Govitecan for Metastatic Breast Cancer

Aleix Prat

Uta Dirksen: Our New Paper on Novel and Deeply Characterized Ewing Sarcoma Cell Lines

Uta Dirksen

Ophira Ginsburg: Perilous Time for the Rights of Women and Girls

Ophira Ginsburg

OncoCalendar

Loading Events

« All Events

  • This event has passed.

The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO

Mar 1 • 12:00 AM - Mar 5 • 12:00 AM
ESTRO Webinar Series

The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO will be going on for two years from March 2025 to November 2026.

The Nordic Radiotherapy Diploma Programme (NORTHDIP) is a two-year advanced education initiative designed for clinical oncologists across the Nordic countries: Denmark, Iceland, Finland, Norway, and Sweden. The programme addresses the need for supplementary radiotherapy training for oncologists who specialize in radiotherapy after their clinical oncology education.

The goal of NORTHDIP is to enhance radiotherapy skills and foster collaboration among Nordic clinical oncologists, ultimately advancing expertise in the region and promoting collaborative research and development in radiotherapy.

The programme’s content is aligned with ESTRO’s core curriculum for radiation oncologists and covers a variety of advanced topics:

  • Sweden 2024: Advanced radiophysics, dose planning, organs-at-risk constraints, and advanced technologies.
  • Norway 2025: Radiobiology, benign diseases, and palliative care.
  • Finland 2025: Reirradiation, stereotactic radiotherapy, and BNCT (Boron Neutron Capture Therapy).
  • Denmark 2026: Adaptive radiotherapy and imaging (CBCT, dual-energy CT, PET-CT, MRI), including the integration of proton and MR-Linac therapy.
  • Iceland 2026: Nordic research protocols, including the design of clinical trials for collaborative Nordic implementation and shared patient recruitment.